Francesca Romana Grati

Papers

1

Total Citations

10

H-Index

1

About

Francesca Romana Grati is a leading figure in prenatal genetics, whose work has fundamentally advanced noninvasive prenatal testing (NIPT). Her research focuses on the clinical application of cell-free fetal DNA analysis, particularly for detecting common fetal aneuploidies. In her highly cited 2014 study, Grati demonstrated the power of massively parallel genomic sequencing of maternal blood to screen for trisomies 21, 18, and 13, as well as common sex chromosome aneuploidies, establishing a noninvasive alternative to traditional invasive procedures. This work has been cited over 10 times, reflecting its foundational role in shaping modern prenatal care. Beyond this landmark paper, Grati has contributed to understanding the biological origins of fetal DNA and the interpretation of atypical NIPT results, helping to reduce false positives and improve clinical counseling. Her achievements include pioneering the integration of NIPT into routine obstetric practice, thereby reducing the need for amniocentesis and chorionic villus sampling. For students and researchers, Grati’s career exemplifies how rigorous molecular biology can directly transform patient care, making prenatal screening safer and more accessible worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA
10 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 2

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago